AIRS Relative Valuation - Airsculpt Technologies Inc

Watchlist Manager

Watchlist

Price: 2.705 USD -0.55%

Market Cap: $168.9m

	Airsculpt Technologies Inc NASDAQ:AIRS	US
	TVS Holdings Ltd NSE:TVSHLTD	IN

Multiples-Based Value

The Multiples-Based Value for Airsculpt Technologies Inc (AIRS) under the Base Case is 4.591 USD. Compared with the current market price of 2.705 USD, the stock appears Undervalued by 41%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

AIRS Multiples-Based Value

Base Case

Undervaluation 41%

Multiples-Based Value

Price $2.705

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		Airsculpt Technologies Inc NASDAQ:AIRS	175.3m USD	1.1	-14.9	27.3	-44.8
US		CVS Health Corp NYSE:CVS	100.1B USD	0.3	56.9	14.4	14.4
US	C	Cigna Group XMUN:CGN	69.6B EUR	0.3	13.4	7.8	10
US		Cigna Corp NYSE:CI	73.1B USD	0.3	12.3	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25.1B EUR	1.1	19.8	9.9	14.7
DE		Fresenius Medical Care AG XMUN:FME	23.3B EUR	1.2	24.3	9.3	17.2
US		Laboratory Corporation of America Holdings NYSE:LH	22.6B USD	1.6	25.8	12.3	17.8
US		Quest Diagnostics Inc NYSE:DGX	21.9B USD	2	22.1	12	16.1
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.2B EUR	0.6	11.4	5.4	10.1
US		Guardant Health Inc NASDAQ:GH	12.1B USD	11.8	-27.8	-30.4	-27.6
US		DaVita Inc NYSE:DVA	10.2B USD	0.8	13.9	7.2	9.7

				Revenue Growth	P/S to Growth
US		Airsculpt Technologies Inc NASDAQ:AIRS	Average P/S: 1.9 1.1	11%	0.1
US		CVS Health Corp NYSE:CVS	0.3	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	2%	0.6
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	2%	0.3
US		Guardant Health Inc NASDAQ:GH	11.8	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
US		Airsculpt Technologies Inc NASDAQ:AIRS	Average P/E: 22.2 Negative Multiple: -14.9	N/A	N/A
US		CVS Health Corp NYSE:CVS	56.9	90%	0.6
US	C	Cigna Group XMUN:CGN	13.4	19%	0.7
US		Cigna Corp NYSE:CI	12.3	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.8	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	24.3	16%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	25.8	27%	1
US		Quest Diagnostics Inc NYSE:DGX	22.1	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.4	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.8	N/A	N/A
US		DaVita Inc NYSE:DVA	13.9	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
US		Airsculpt Technologies Inc NASDAQ:AIRS	Average EV/EBITDA: 11.7 27.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	14.4	28%	0.5
US	C	Cigna Group XMUN:CGN	7.8	4%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.9	10%	1
DE		Fresenius Medical Care AG XMUN:FME	9.3	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12.3	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	12	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.4	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -30.4	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8

				EBIT Growth	EV/EBIT to Growth
US		Airsculpt Technologies Inc NASDAQ:AIRS	Average EV/EBIT: 13.7 Negative Multiple: -44.8	N/A	N/A
US		CVS Health Corp NYSE:CVS	14.4	22%	0.7
US	C	Cigna Group XMUN:CGN	10	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14.7	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	17.2	11%	1.6
US		Laboratory Corporation of America Holdings NYSE:LH	17.8	18%	1
US		Quest Diagnostics Inc NYSE:DGX	16.1	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.1	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.6	N/A	N/A
US		DaVita Inc NYSE:DVA	9.7	5%	1.9

Airsculpt Technologies Inc
NASDAQ:AIRS

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

AIRS Competitors Multiples
Airsculpt Technologies Inc Competitors

See Also

Company

Help

Tools

Stocks

Airsculpt Technologies Inc NASDAQ:AIRS

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

AIRS Competitors Multiples Airsculpt Technologies Inc Competitors

See Also

Company

Help

Tools

Stocks

Airsculpt Technologies Inc
NASDAQ:AIRS

AIRS Competitors Multiples
Airsculpt Technologies Inc Competitors